P1230: T CELL CD62L EXPRESSION FOLLOWING NIVOLUMAB THERAPY IS ASSOCIATED WITH LONG TERM RESPONSE TO RITUXIMAB-NIVOLUMAB IN TREATMENT NAÏVE FOLLICULAR LYMPHOMA: RESULTS FROM THE 1ST FLOR STUDY

• Rachel Koldej,
• Allison Barraclough,
• Sze Ting Lee,
• Huw Morgan,
• Nicholas Holzwart,
• Minu Koshy,
• Charmaine Smith,
• Geoff Chong,
• Michael Gilbertson,
• Colm Keane,
• Stephen Ting,
• Leonid Churilov,
• David Ritchie,
• Eliza A. Hawkes

Affiliations

Rachel Koldej

1 The Royal Melbourne Hospital, ACRF Translational Research Laboratory, Parkville, Australia

Allison Barraclough

3 Fiona Stanley Hospital, Haematology, Murdoch, Australia

Sze Ting Lee

4 Austin Health, Molecular Imaging and Therapy, Heidelberg, Australia

Huw Morgan

1 The Royal Melbourne Hospital, ACRF Translational Research Laboratory, Parkville, Australia

Nicholas Holzwart

1 The Royal Melbourne Hospital, ACRF Translational Research Laboratory, Parkville, Australia

Minu Koshy

5 Austin Health, Anatomical Pathology, Heidelberg, Australia

Charmaine Smith

6 Austin Health, Cancer Clinical Trials Centre, Heidelberg, Australia

Geoff Chong

7 Ballarat Regional Integrated Cancer Centre (BRICC), Haematology and Oncology, Ballarat Central, Australia

Michael Gilbertson

8 Monash Health, Haematology, Australia

Colm Keane

9 The University of Queensland, Saint Lucia, Australia

Stephen Ting

10 Eastern Health, Box Hill, Australia

Leonid Churilov

11 The Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre, Parkville, Australia

David Ritchie

1 The Royal Melbourne Hospital, ACRF Translational Research Laboratory, Parkville, Australia

Eliza A. Hawkes

13 Olivia Newton-John Cancer Wellness & Research Centre, Medical Oncology and Haematology, Heidelberg, Australia